IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
48 hedge funds and large institutions have $105M invested in Ibere Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
48
Holding in Top 10
1
Calls
$23K
Puts
–
Top Buyers
| 1 | +$4.14M | |
| 2 | +$3.43M | |
| 3 | +$3.14M | |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
+$1.13M |
| 5 |
SCM
Saba Capital Management
New York
|
+$785K |
Top Sellers
| 1 | -$2.27M | |
| 2 | -$1.94M | |
| 3 | -$1.62M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.31M |
| 5 |
HIH
HRS Investment Holdings
New York
|
-$1.09M |